SS
AURA icon

SBI Securities’s Aura Biosciences AURA Stock Holding History

SBI Securities’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241 Hold
34
– – ﹤0.01% 3270
2026
Q1 		$227 Sell
34
-600
-95% -$3.44K ﹤0.01% 3175
2025
Q4 		$3.46K Sell
634
-2
-0.3% -$12 ﹤0.01% 2176
2025
Q3 		$3.93K Buy
636
+2
+0.3% +$13 ﹤0.01% 2144
2025
Q2 		$3.97K Buy
634
+300
+90% +$1.75K ﹤0.01% 2098
2025
Q1 		$1.96K Hold
334
– – ﹤0.01% 2301
2024
Q4 		$2.75K Buy
+334
New +$3.14K ﹤0.01% 2174

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

SBI Securities's AURA Position: Q2 2026 in Review

SBI Securities held its Aura Biosciences (AURA) position steady in Q2 2026 at 34 shares worth $241. The position accounts for ﹤0.01% of the portfolio, ranked #3270.

SBI Securities first reported a position in AURA in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.97K in Q2 2025. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • SBI Securities held 34 shares of Aura Biosciences worth $241 as of Q2 2026.
  • SBI Securities left its Aura Biosciences share count unchanged in Q2 2026.
  • Aura Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3270 holding.
  • SBI Securities first reported a position in Aura Biosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Aura Biosciences position peaked at $3.97K in Q2 2025.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.